Search Results: Displaying all items (105)

First Author Title Journal Publication Date
Edwards A. Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis. Thorax 2017
Abreu C. The tuberculin skin test still matters for the screening of latent Tuberculosis infections among Inflammatory Bowel Disease patients. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2016
Matsumura R. Comparative utility of interferon-γ release assay, QuantiFERON(®) TB-GIT and T-SPOT(®).TB in rheumatoid arthritis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2016
Clifford V. The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays. Tuberculosis (Edinburgh, Scotland) 2015
Raval A. Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab. Annals of internal medicine 2007
Lee H. QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment. PloS one 2015
Shim TS. Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy. Intestinal research 2014
Kim JH. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents. International journal of rheumatic diseases 2014
Muñoz L. Prevention of Anti-Tumor Necrosis Factor-Associated Tuberculosis: A 10-Year Longitudinal Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014
Kim HC. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay. Scandinavian journal of infectious diseases 2014
Son CN. Follow-up Testing of Interferon-Gamma Release Assays Are Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor Necrosis Factor Alpha for Latent Tuberculosis Infection. Journal of Korean medical science 2014
Sharma A. A case of peritoneal TB causing renal failure in a patient with rheumatoid arthritis and initial negative PPD after treatment with infliximab. Renal failure 2014
Prignano F. Latent tuberculosis infection in psoriasis and other dermatological immunomediated diseases: a combined approach by QuantiFERON(®) -TB Gold and tuberculin skin tests. International journal of dermatology 2014
Scrivo R. The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature. Clinical rheumatology 2014
Reichmann MT. Tuberculosis and TNF-inhibitors: history of exposure should outweigh investigations. BMJ case reports 2014
Suh YS. Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy. Journal of Korean medical science 2014
Felber A. Weakly positive tests and chronologic variation of the QuantiFERON assay: A retrospective appraisal of usefulness. Tuberculosis (Edinburgh, Scotland) 2013
Swaminath A. Cost-effectiveness of QuantiFERON Testing Before Initiation of Biological Therapy in Inflammatory Bowel Disease. Inflammatory bowel diseases 2013
Sauzullo I. IFN-γ release assay for tuberculosis in psoriasis patients treated with TNF antagonists: in vivo and in vitro analysis. The British journal of dermatology 2013
Drago L. Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy. Dermatology and therapy 2013
Load More Results